Amylyx Pharmaceuticals (AMLX) Interest & Investment Income (2021 - 2025)
Historic Interest & Investment Income for Amylyx Pharmaceuticals (AMLX) over the last 5 years, with Q3 2025 value amounting to $1.8 million.
- Amylyx Pharmaceuticals' Interest & Investment Income fell 4122.01% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.3 million, marking a year-over-year decrease of 4750.38%. This contributed to the annual value of $13.8 million for FY2024, which is 1452.18% down from last year.
- Amylyx Pharmaceuticals' Interest & Investment Income amounted to $1.8 million in Q3 2025, which was down 4122.01% from $2.0 million recorded in Q2 2025.
- Over the past 5 years, Amylyx Pharmaceuticals' Interest & Investment Income peaked at $4.4 million during Q4 2023, and registered a low of $1000.0 during Q2 2021.
- In the last 5 years, Amylyx Pharmaceuticals' Interest & Investment Income had a median value of $2.2 million in 2025 and averaged $2.1 million.
- In the last 5 years, Amylyx Pharmaceuticals' Interest & Investment Income surged by 4010000.0% in 2022 and then tumbled by 5183.09% in 2025.
- Amylyx Pharmaceuticals' Interest & Investment Income (Quarter) stood at $30000.0 in 2021, then skyrocketed by 10423.33% to $3.2 million in 2022, then skyrocketed by 38.45% to $4.4 million in 2023, then plummeted by 47.01% to $2.3 million in 2024, then dropped by 21.37% to $1.8 million in 2025.
- Its Interest & Investment Income stands at $1.8 million for Q3 2025, versus $2.0 million for Q2 2025 and $2.2 million for Q1 2025.